256 related articles for article (PubMed ID: 11313257)
1. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway.
Kawakami K; Taguchi J; Murata T; Puri RK
Blood; 2001 May; 97(9):2673-9. PubMed ID: 11313257
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors.
Murata T; Taguchi J; Puri RK
Blood; 1998 May; 91(10):3884-91. PubMed ID: 9573026
[TBL] [Abstract][Full Text] [Related]
3. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
David M; Ford D; Bertoglio J; Maizel AL; Pierre J
Oncogene; 2001 Oct; 20(46):6660-8. PubMed ID: 11709700
[TBL] [Abstract][Full Text] [Related]
4. Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain.
Kawakami K; Takeshita F; Puri RK
J Biol Chem; 2001 Jul; 276(27):25114-20. PubMed ID: 11352909
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.
Joshi BH; Kawakami K; Leland P; Puri RK
Clin Cancer Res; 2002 Jun; 8(6):1948-56. PubMed ID: 12060640
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer.
Kawakami K; Kawakami M; Joshi BH; Puri RK
Cancer Res; 2001 Aug; 61(16):6194-200. PubMed ID: 11507072
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity.
Andrews R; Rosa L; Daines M; Khurana Hershey G
J Immunol; 2001 Feb; 166(3):1716-22. PubMed ID: 11160216
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interaction between interleukin-13 and interleukin-13 receptors.
Arima K; Sato K; Tanaka G; Kanaji S; Terada T; Honjo E; Kuroki R; Matsuo Y; Izuhara K
J Biol Chem; 2005 Jul; 280(26):24915-22. PubMed ID: 15870068
[TBL] [Abstract][Full Text] [Related]
9. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.
Daines MO; Tabata Y; Walker BA; Chen W; Warrier MR; Basu S; Hershey GK
J Immunol; 2006 Jun; 176(12):7495-501. PubMed ID: 16751396
[TBL] [Abstract][Full Text] [Related]
10. IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.
Mintz A; Gibo DM; Slagle-Webb B; Christensen ND; Debinski W
Neoplasia; 2002; 4(5):388-99. PubMed ID: 12192597
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression.
David MD; Bertoglio J; Pierre J
Oncogene; 2003 May; 22(22):3386-94. PubMed ID: 12776189
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
Kawakami K; Husain SR; Bright RK; Puri RK
Cancer Gene Ther; 2001 Nov; 8(11):861-8. PubMed ID: 11773976
[TBL] [Abstract][Full Text] [Related]
13. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
[TBL] [Abstract][Full Text] [Related]
14. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
Andrews AL; Holloway JW; Holgate ST; Davies DE
J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2.
Feng N; Lugli SM; Schnyder B; Gauchat JF; Graber P; Schlagenhauf E; Schnarr B; Wiederkehr-Adam M; Duschl A; Heim MH; Lutz RA; Moser R
Lab Invest; 1998 May; 78(5):591-602. PubMed ID: 9605184
[TBL] [Abstract][Full Text] [Related]
16. Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease.
Kawakami K; Kawakami M; Puri RK
Mol Cancer Ther; 2004 Feb; 3(2):137-47. PubMed ID: 14985454
[TBL] [Abstract][Full Text] [Related]
17. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of the interleukin-13 receptor complex.
Andrews AL; Holloway JW; Puddicombe SM; Holgate ST; Davies DE
J Biol Chem; 2002 Nov; 277(48):46073-8. PubMed ID: 12354755
[TBL] [Abstract][Full Text] [Related]
19. Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts.
Chandriani S; DePianto DJ; N'Diaye EN; Abbas AR; Jackman J; Bevers J; Ramirez-Carrozzi V; Pappu R; Kauder SE; Toy K; Ha C; Modrusan Z; Wu LC; Collard HR; Wolters PJ; Egen JG; Arron JR
J Immunol; 2014 Jul; 193(1):111-9. PubMed ID: 24879793
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.
Zhao Y; He D; Zhao J; Wang L; Leff AR; Spannhake EW; Georas S; Natarajan V
J Biol Chem; 2007 Apr; 282(14):10172-9. PubMed ID: 17287216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
